Skip to main content

Belgian biotech companies DeuterOncology and Radiomics combine their expertise to improve cancer therapy

Belgian biotech companies DeuterOncology and Radiomics combine their expertise to improve cancer therapy DeuterOncology obtains SPW grant funding Liège, Belgium, April 07, 2023 – DeuterOncology, a Liège-Based (BE) biotech company, is pleased to announce it has successfully been awarded the Win4Company grant by the Wallonie recherche SPW. The clinical-stage drug...
Read More

ImmuneWatch, Quantoom Biosciences (Univercells) and UAntwerp join forces to explore new in vitro and in silico assays that predict T cell responses in vaccines

March 30, 2023 Quantoom Biosciences (“Quantoom”), ImmuneWatch and UAntwerp (Lab of Experimental Hematology) are delighted to announce a public-private partnership in a project under the “Pandemic Preparedness” call, launched by the University of Antwerp in 2022. “The goal of this project is to assess if a detailed analysis of the...
Read More

Quantoom Biosciences is growing in France with brand-new facilities for its DNA and enzymes activity located in Evry (Région Île-de-France)

Brussels (Belgium) – March 2, 2023 Quantoom Biosciences S.A. (“Quantoom”), a Belgian biotech with the mission to reinvent mRNA production announces today the opening of a brand-new facility in Évry-Courcouronnes (France). Following the SynHelix acquisition in 2021, Quantoom already had infrastructures in France, part of the Genopole campus, but these…

Read More

ABSCINT and the VUB announce a Notice of Allowance for their U.S. Patent covering diagnostic applications of its single-domain antibody labelled with radioisotopes for PET/CT imaging of HER2 cancer lesions

  Brussels, Liège, February 20, 2023. Vrije Universiteit Brussel (VUB) and its spin-off ABSCINT announce today that the United States Patent and Trademark Office (“USPTO”) has provided a Notice of Allowance for patent application No. 16/827,032, entitled “Radio-labelled antibody fragments for use in the prognosis and diagnosis of cancer as well as for the…

Read More

La Belgique renforce sa position stratégique dans le secteur pharmaceutique grâce à un entrepôt ultramoderne

La Belgique renforce sa position stratégique dans le secteur pharmaceutique grâce à un entrepôt ultramoderne MG Real Estate, Yusen Logistics Benelux et GSK posent le premier pilier d’un hub logistique de soins de santé avec traitement automatisé des commandes Gembloux, 20 décembre 2022 – MG Real Estate, Yusen Logistics et…

Read More

Analis takes over VOS instrumenten

Analis takes a big step forward by acquiring the Dutch company Vos Instrumenten. With nearly 100 years of experience, Analis offers a wide range of scientific and laboratory equipment with its team of more than 150 employees. The company is highly recognized for its expertise and the quality of its...
Read More